Markets.com Logo

457190

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    46176.3186$
  • Previous Close
    48119.3199$
  • 52 Week Change
    37750.00$
  • Day Range
    -1943.00$
  • 52 Week High/Low
    29050$ - 66800$
  • Dividend Per Share
    --
  • Market cap
    1 440 042 M$
  • EPS
    -136.8687
  • Beta
    --
  • Volume
    --

About

457190.KO represents HLB, a South Korean pharmaceutical company listed on the Korea Exchange (KRX). The company is involved in the research, development, manufacturing, and marketing of pharmaceuticals, primarily focusing on oncology, cardiovascular, and central nervous system therapies. HLB also invests in and develops biotech companies specializing in innovative drug candidates and technologies. Its main product candidate is Rivoceranib, an anti-cancer agent.
SOUN stock analysis: What’s happening with SoundHound AI Inc?

SOUN stock analysis: What’s happening with SoundHound AI Inc?

Frances Wang|--
Silver price XAGUSD forecast: Is silver expected to drop or rise?

Silver price XAGUSD forecast: Is silver expected to drop or rise?

Ghko B|--
UAE stock market analysis: Which is the best stock to buy in the UAE?

UAE stock market analysis: Which is the best stock to buy in the UAE?

Ghko B|--
How to invest in Bitcoin in South Africa: What if you invested $1000 in Bitcoin 10 years ago?

How to invest in Bitcoin in South Africa: What if you invested $1000 in Bitcoin 10 years ago?

Ghko B|--
What is the best European stock to buy: ASML stock, Rheinmetall stock, Novo Nordisk stock

What is the best European stock to buy: ASML stock, Rheinmetall stock, Novo Nordisk stock

Ghko B|--
Solana Price Prediction 2026, 2030, 2040: What Will SOL Be Worth in 5 Years?

Solana Price Prediction 2026, 2030, 2040: What Will SOL Be Worth in 5 Years?

Ghko B|--
Nasdaq 100 Analysis: What Are the Levels to Watch in the Nasdaq 100?

Nasdaq 100 Analysis: What Are the Levels to Watch in the Nasdaq 100?

Frances Wang|--

Factors

Industry Trends: Overall performance of the pharmaceutical industry influences investor sentiment regarding Komipharm.

Company Performance: Komipharm's revenue, profit margins, and drug development pipeline progress affect its stock price.

Regulatory Environment: Changes in pharmaceutical regulations, drug approval processes, and patent laws impact Komipharm's prospects.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth influence investment decisions in Komipharm stock.

Market Sentiment: General investor confidence and risk appetite affect demand for Komipharm shares.

Competition: The competitive landscape, including competitor activities and new drug launches, influences Komipharm's market position and stock value.

Global Events: Geopolitical events and global health crises can affect the pharmaceutical industry and Komipharm's stock price.

People Also Watch

Latest news

NVDA News Today: Developments in NVIDIA AI Ecosystem Partnerships

NVDA News Today: Developments in NVIDIA AI Ecosystem Partnerships

Frances Wang|--
Gold price today, May 14: XAU/USD near $4,700, gold steady ahead of Trump-Xi talks

Gold price today, May 14: XAU/USD near $4,700, gold steady ahead of Trump-Xi talks

Ghko B|--
Record Inflows Pour into South African Markets Amid Reform Momentum: $42 Billion Foreign Investment Surge

Record Inflows Pour into South African Markets Amid Reform Momentum: $42 Billion Foreign Investment Surge

Ghko B|--

Latest Education Articles

What Is MACD? Indicator Meaning, Formula and Trading Signals

What Is MACD? Indicator Meaning, Formula and Trading Signals

Julian Parker|--
What Is On-Balance Volume (OBV)? Meaning, Formula and Trading Signals

What Is On-Balance Volume (OBV)? Meaning, Formula and Trading Signals

Julian Parker|--
Silver ETF vs Physical Silver: Which Is Better for Silver Exposure?

Silver ETF vs Physical Silver: Which Is Better for Silver Exposure?

Julian Parker|--
Recommended Topics